Literature DB >> 10754381

Four cases of bleeding diathesis in children due to congenital plasminogen activator inhibitor-1 deficiency.

H Minowa1, Y Takahashi, T Tanaka, K Naganuma, S Ida, I Maki, A Yoshioka.   

Abstract

Congenital plasminogen activator inhibitor-1 (PAI-1) deficiency is an extremely rare disorder characterized by a bleeding diathesis that begins in childhood due to hyperfibrinolysis as a result of decreased PAI-1 activity. We now present 4 unrelated pediatric cases of congenital PAI-1 deficiency. All 4 patients had a history of recurrent episodes of subcutaneous bleeding beginning in early childhood. These episodes were characterized by abnormal prolonged bleeding after trauma, tooth extraction, and surgical procedures, as well as by rebleeding following initial hemostasis. The 2 female patients both had symptoms compatible with hypermenorrhea. The family history was positive in 2 of the 4 patients. Hemostatic screening studies in all 4 patients revealed no abnormalities. Testing for factor XIII antigen, von Willebrand factor antigen, ristocetin cofactor activity, alpha(2)-plasmin inhibitor (alpha2PI) activity, and plasminogen activity was normal. The euglobulin lysis times were shortened in all cases as compared with those in normal control subjects. None of the patients had elevated tissue plasminogen activator (tPA) antigen levels, but PAI activity was markedly decreased in all cases. Three of the patients also had reduced levels of PAI-1 antigen. There tended to be a reduction in tPA-PAI-1 complex in all cases. In addition, 2 patients had elevated PIC (plasmin-alpha2PI complex). Tourniquet tests were performed in 2 patients, with no appreciable rise in PAI-1 activity or PAI-1 antigen levels. The administration of tranexamic acid clearly improved hemorrhagic symptoms in these patients. We considered PAI-1 deficiency to be the likely etiology of the congenital bleeding diatheses in these 4 cases. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10754381     DOI: 10.1159/000022514

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  12 in total

1.  Bleeding diathesis in a child with normal screening tests: think about fibrinolysis.

Authors:  Vanessa Largent; Véronique Deneys; Bénédicte Brichard; Christophe Chantrain; Christiane Vermylen
Journal:  Eur J Pediatr       Date:  2005-06-07       Impact factor: 3.183

2.  Massive subhyaloidal hemorrhage associated with severe PAI-1 deficiency.

Authors:  Claudia Kuhli; Marc Lüchtenberg; Inge Scharrer; Lars-Olof Hattenbach
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

3.  The α-globin chain of hemoglobin potentiates tissue plasminogen activator induced hyperfibrinolysis in vitro.

Authors:  Alexander P Morton; Jamie B Hadley; Arsen Ghasabyan; Marguerite R Kelher; Ernest E Moore; Shaun Bevers; Monika Dzieciatkowska; Kirk C Hansen; Mitchell S Cohen; Anirban Banerjee; Christopher C Silliman
Journal:  J Trauma Acute Care Surg       Date:  2022-01-01       Impact factor: 3.697

4.  Low Molecular Weight Antagonists of Plasminogen Activator Inhibitor-1: Therapeutic Potential in Cardiovascular Disease.

Authors:  Tessa M Simone; Paul J Higgins
Journal:  Mol Med Ther       Date:  2012-08-05

Review 5.  Clinical practice: the bleeding child. Part II: disorders of secondary hemostasis and fibrinolysis.

Authors:  Femke van Herrewegen; Joost C M Meijers; Marjolein Peters; C Heleen van Ommen
Journal:  Eur J Pediatr       Date:  2011-09-17       Impact factor: 3.183

6.  Chemical Antagonists of Plasminogen Activator Inhibitor-1: Mechanisms of Action and Therapeutic Potential in Vascular Disease.

Authors:  Tessa M Simone; Stephen P Higgins; Craig E Higgins; Michelle R Lennartz; Paul J Higgins
Journal:  J Mol Genet Med       Date:  2014-10

Review 7.  Functional stability of plasminogen activator inhibitor-1.

Authors:  Songul Yasar Yildiz; Pinar Kuru; Ebru Toksoy Oner; Mehmet Agirbasli
Journal:  ScientificWorldJournal       Date:  2014-10-15

8.  Application of long-acting VLHL PAI-1 during sutureless partial nephrectomy in mice reduces bleeding.

Authors:  Khaled Shahrour; Rick Keck; Jerzy Jankun
Journal:  Biomed Res Int       Date:  2015-03-26       Impact factor: 3.411

9.  Effects of epinephrine on angiogenesis-related gene expressions in cultured rat cardiomyocytes.

Authors:  Henry Liu; Lisa Sangkum; Geoffrey Liu; Michael Green; Marilyn Li; Alan Kaye
Journal:  J Biomed Res       Date:  2016-04-30

Review 10.  Bleeding Disorders in Primary Fibrinolysis.

Authors:  Massimo Franchini; Marco Zaffanello; Pier Mannuccio Mannucci
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.